Trial Profile
A phase II study of low dose nab-paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 16 Jan 2015 New trial record